Drug interactions
Dimenhydrinate + Indacaterol-glycopyrronium
Severity: Minor
Dimenhydrinate and Indacaterol-glycopyrronium: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Dimenhydrinate has strong anticholinergic activity and inhaled glycopyrronium adds to the antimuscarinic load. This can cause dry mouth, urinary retention, constipation, blurred vision and confusion, particularly in older adults.
What this interaction means in plain words
Dimenhydrinate and Indacaterol-glycopyrronium have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Dimenhydrinate belongs to Respiratory; Indacaterol-glycopyrronium belongs to Respiratory.
Why it happens
Additive antimuscarinic effects.
What to do
Monitor for anticholinergic effects such as urinary retention, constipation and confusion. Avoid prolonged combined use in elderly patients or those with glaucoma or prostatic hypertrophy.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dimenhydrinate and Indacaterol-glycopyrronium, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Indacaterol-glycopyrronium
Other interactions of Dimenhydrinate
Frequently asked questions
Can I take Dimenhydrinate with Indacaterol-glycopyrronium?
MediHelp rates the interaction as minor. Dimenhydrinate and Indacaterol-glycopyrronium have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Dimenhydrinate has strong anticholinergic activity and inhaled glycopyrronium adds to the antimuscarinic load. This can cause dry mouth, urinary retention, constipation, blurred vision and confusion, particularly in older adults.
How serious is the interaction between Dimenhydrinate and Indacaterol-glycopyrronium?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for anticholinergic effects such as urinary retention, constipation and confusion. Avoid prolonged combined use in elderly patients or those with glaucoma or prostatic hypertrophy.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
